Dr. Yonghong Hua 花永虹
Chief Physician
Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Precision radiotherapy, chemotherapy, and targeted therapy for head and neck malignancies.
Dr. Hua holds a PhD and has worked in the Radiotherapy Department at Zhejiang Cancer Hospital since graduating from Fudan University Shanghai Cancer Center in 2004. Focus includes radiotherapy and comprehensive treatment for head and neck malignancies. In the past three years, Dr. Hua led or participated in five provincial-level projects and authored over ten professional papers, including one SCI-indexed article.
Professional roles
- Youth Committee Member, Nasopharyngeal Carcinoma Professional Committee, China Anti-Cancer Association
- Member, Rehabilitation and Palliative Care Professional Committee, Zhejiang Anti-Cancer Association
Name order: in Chinese the family name comes first (Hua Yonghong). Papers usually list the name as Yonghong Hua or Hua Y.
Selected publications
32 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- Am J Cancer Res, 2024 (senior author): Specific-CT brain template construction and retrospective dosimetric comparison study in brain for nasopharyngeal carcinoma patients treated with IMRT or VMAT. PubMed 38726278
- Front Oncol, 2022 (first author): Anti-PD-1 Monoclonal Antibody Combined With Anti-VEGF Agent Is Safe and Effective in Patients With Recurrent/Metastatic Head and Neck Squamous Cancer as Second-Line or Beyond Treatment. PubMed 35280787
- Biochem Biophys Res Commun, 2018 (senior author): Polyphyllin I inhibits gastric cancer cell proliferation by downregulating the expression of fibroblast activation protein alpha (FAP) and hepatocyte growth factor (HGF) in cancer-associated fibroblasts. PubMed 29499193
- Onco Targets Ther, 2016 (senior author): Correlation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcinoma patients. PubMed 27217776
- J Cancer Res Ther, 2015 (first author): Effect of capilliposide for induction apoptosis in human nasopharyngeal cancer CNE-2 cells through up-regulating PUMA expression. PubMed 26612445
- Head Neck, 2015 (first author): Effect of number and ratio of positive lymph nodes in hypopharyngeal cancer. PubMed 24347492
- Zhonghua Zhong Liu Za Zhi, 2014 (first author): [Prognostic significance of the number of positive lymph nodes, number of involved regions and metastatic lymph node ratio in hypopharyngeal cancer]. PubMed 25567312
- Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2012 (first author): [Clinicopathological and prognostic analysis of 178 patients with hypopharyngeal cancer]. PubMed 22932236
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion